Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The combination of cyproheptadine and dexamethasone is a pharmaceutical preparation that has been used for various purposes, particularly for weight gain, appetite stimulation, and treatment of inflammatory conditions. This combination has both therapeutic uses and potential for misuse. ## Pharmacology and Mechanism of Action Cyproheptadine is a first-generation antihistamine with additional antiserotonergic and anticholinergic properties. It's primarily used to treat allergic conditions but has notable off-label uses for appetite stimulation and weight gain[1][6]. It works by competing with free histamine and serotonin for binding at their respective receptors, antagonizing their effects[6]. Dexamethasone is a potent synthetic glucocorticoid with strong anti-inflammatory and immunosuppressant properties. It's used to treat various inflammatory conditions including rheumatoid arthritis, asthma, allergies, and autoimmune disorders[5][10]. When combined, these medications have a synergistic effect. The presence of cyproheptadine has been found to have a "steroid sparing effect," meaning that the same therapeutic benefit can be achieved with a smaller amount of dexamethasone than would be required if cyproheptadine were absent[7]. ## Medical Uses and Misuse The combination has legitimate medical applications for treating inflammatory conditions, allergic reactions, and as an appetite stimulant. However, there are concerning reports of misuse and dependence: 1. **Weight gain and muscle development**: The combination is frequently misused by individuals seeking rapid weight gain and muscle development[1][5]. 2. **Dependence**: Multiple case reports document dependence on this combination, with withdrawal symptoms including loss of appetite, insomnia, fatigue, headache, tremors, and increased frequency of bowel movements[5]. 3. **Psychiatric effects**: There are reports of psychiatric side effects, including obsessive-compulsive symptoms and suicidality, developing within a week of using this combination[4]. ## Side Effects and Risks The combination carries risks associated with both medications: - **Cyproheptadine side effects**: Drowsiness, dizziness, blurred vision, dry mouth, constipation, excitability, nervousness, and restlessness[5]. - **Dexamethasone side effects**: Insomnia, indigestion, fluid retention, electrolyte imbalances, weight gain, increased appetite, nausea, and truncal obesity[1]. - **Psychiatric disturbances**: Both medications can cause psychiatric effects, with dexamethasone linked to anxiety, depression, mood lability, mania, and psychosis, while cyproheptadine has been reported to cause obsessive-compulsive disorders and worsen depression[1][4]. - **Combined effects**: The combination may result in additive central nervous system depression and impairment of judgment, thinking, and psychomotor skills[9]. ## Historical Context A patent from the 1960s (US3231468A) describes pharmaceutical preparations containing both dexamethasone and cyproheptadine, highlighting the discovery that adding cyproheptadine reduces the required amount of dexamethasone while maintaining therapeutic efficacy[7]. This combination has been studied for its potential benefits in treating various conditions, with research suggesting that specific dosages (such as 4mg cyproheptadine with 0.5mg dexamethasone) may enhance the antipruritic properties of cyproheptadine while providing mild steroid effects[2]. Despite its therapeutic potential, the risk of dependence and adverse effects necessitates careful monitoring and appropriate medical supervision when using this combination.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on cyproheptadine + dexamethasone.